A healthy male and female between 20 and 64 years old with a BMI of 25 or more and less than 30
Conditions
Interventions
Administration of functional nozawana processed food withhigh-glucosinolates + Lactic acid bacteria of 5 g/day for three months
Administration of functional nozawana processed food withhigh-glucosinol
Sponsors
National Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Candidate patients have to meet all the following inclusion criteria to participate in the study. (1) Male and female aged 20 to 65 years old at the time of acquisition (2) Persons whose BMI is 25 or more and less than 30 (3) A person who received a sufficient explanation about the examination, can understand the contents, obtains document consent by the principal
Exclusion criteria
Exclusion criteria: (1) Persons who regularly eat medicines, functional display foods, foods for specified health use, health foods, etc., which are likely to affect the test results (2) Those currently on a diet or planning to diet (3) Those who eat more than 200 g of Nozawana pickles a day (4) Heavy alcohol drinkers (5) Persons with extremely irregular eating habits, those with irregular life rhythms (6) Persons who have a severe current medical history in the heart, liver, kidney and digestive organs (7) Those pregnant or planning pregnancy, and those who are breastfeeding (8) Persons who are allergic to pharmaceuticals and foods (in particular Nozawana product) (9) Those who donated blood donated from the previous month or started donating 200 mL of whole blood (10) A man who donated 400 mL of whole blood three months before the start of the test (11) Women who donated 400 mL of whole blood from 4 months before the start of the test (12) A man who may donate more than 1,200 mL of whole blood from 12 months plus total blood draw amount of this test. (13) Women who may donate more than 800 mL of whole blood from 12 months plus total blood draw amount of this test. (14) Person who judged that participation in the examination is inappropriate by the investigator (medical doctor) or exam sharing physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in body fat percentage after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in serum lipid level, body weight, BMI, Intestinal flora, stool frequency / week and shape | — |
Countries
Japan
Contacts
Public ContactMichihiro Mutoh
Research Center for Cancer Prevention and Screening, National Cancer Center Division of Prevention
Outcome results
None listed